Home > Drug Search >
  • Targets: Growth hormone releasing factor (GHRF)
  •   > 
Drug Filter
Category:
chemistry (26) biology (2)
Status:
Approved (5) Phase Ⅲ (3) Phase Ⅱ (10) Phase Ⅰ (10)
Clinical Stage:
Pending (5) Active (8) Discontinued (10)
Company:
Sumitomo Dainippon (1) Edison pharmaceuticals (1) Eisai (1) Gilead (1) Ipsen (1) Japan Tobacco (1) Johnson & Johnson (2) Kadmon (1) Lantheus Medical Imaging (1) Leo Pharma (1) Ligand (1) Merck Serono (1) National Cancer Institute (1) Novartis (1) Sanofi (1) SK biopharmaceuticals (1) Unknown (1) VUFB (1) Scherer Healthcare (1) Immatics biotechnologies (2) Oncovir (1) University Hospitals of Geneva (1) Biomeasure (1) Italfarmaco (1) MEI Pharma (1) Institute of Materia Medica Chinese Academy of Medical Sciences (1) Novogen (1) Aileron Therapeutics (1) Theratechnologies (1) Cancer Research UK (1) Fitness Biotechnology (1) CalciMedica (1) Aegerion (2) Bristol-Myers Squibb (1)
Indication:
Amyotrophic lateral sclerosis (ALS) (1) Coronary artery disease (CAD) (1) Gastrointestinal haemorrhage (1) Rheumatic disorders (4) Growth hormone deficit (1) HIV infection (1) Hypercholesterolemia (2) Hyperlipidemia (3) Hypertriglyceridemia (1) Somatotropin deficiency (2) Obesity (1) Parkinson's disease (PD) (2) Rheumatoid arthritis (RA) (1) Solid tumours (1) Type 2 diabetes (3) Ulcerative colitis (1) Colorectal cancer (1) Homozygous familial hypercholesterolemia (1) Acromegaly (2) Dwarfism (1) Turner syndrome (1) Skin ulcer (1) Glioblastoma (1) Neuroendocrine tumors (NET) (1) Plaque psoriasis (1) Lipodystrophy (1) Diabetic neuropathy (1)
Country:
Aprv. Year:
2012 (1) 2013 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top